Related Experiment Video
Updated: Jun 12, 2025

Microfluidics in Assessing Platelet Function
Published on: November 8, 2024
Dynamics of Thrombogenicity and Platelet Function and Correlation with Bleeding Risk in Patients Undergoing M-TEER
Miriam Euper1, Jürgen Schreieck1, Mareike Bladt1
1Department of Cardiology and Angiology, University Hospital Tübingen, Germany.
Platelet function changes after mitral transcatheter edge-to-edge repair (M-TEER) correlate with bleeding risk. ADP receptor pathway inhibition is a key predictor of post-procedural bleeding events.
Area of Science:
- Cardiovascular Medicine
- Interventional Cardiology
- Hematology
Background:
- Transcatheter mitral valve repair (M-TEER) patients face risks of thrombotic and bleeding events.
- The impact of M-TEER on platelet function and its link to bleeding complications remains under-examined.
Purpose of the Study:
- To investigate the association between platelet function parameters, thrombogenicity, and bleeding events following M-TEER.
Main Methods:
- 100 patients undergoing M-TEER were analyzed.
- Platelet function was assessed pre- and post-procedure using impedance aggregometry (Multiplate) and thromboelastography (TEG6s).
- Bleeding complications were tracked for 6 months post-procedure.
Main Results:
- 41 patients experienced bleeding events.
- M-TEER led to decreased ADP aggregation and increased ADP inhibition.
- Platelet function tests, particularly the delta-ADP-Test, showed predictive value for bleeding events, improving risk prediction when combined with clinical factors.
Conclusions:
- Thrombogenicity is altered immediately post-M-TEER, likely due to altered flow dynamics.
- Platelet aggregation via the ADP receptor pathway is significantly linked to post-procedural bleeding.
- Further research is needed to determine if these findings can guide antithrombotic therapy and improve patient outcomes.
More Related Videos
09:38A Microfluidic Flow Chamber Model for Platelet Transfusion and Hemostasis Measures Platelet Deposition and Fibrin Formation in Real-time
Published on: February 14, 2017
10:25Microfluidic Flow Chambers Using Reconstituted Blood to Model Hemostasis and Platelet Transfusion In Vitro
Published on: March 19, 2016
Related Concept Videos
Formation of the Platelet Plug
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Structure and Function of Platelets
Platelets are continually replenished, circulating in the bloodstream for 9-12 days before being removed by phagocytes, primarily in the spleen. A microliter of circulating blood contains between 150,000 and 450,000...
Introduction to Hemostasis
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized,...
Disorders of Hemostasis
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.